Pharma Reaserch Prod Co Ltd (214450) — Free Cash Flow Generation Index
Pharma Reaserch Prod Co Ltd (214450) has a Free Cash Flow Generation Index of 0.87x as of December 2025. Free cash flow of ₩53.74 Billion represents 1% of operating cash flow (₩61.53 Billion). Explore how much does Pharma Reaserch Prod Co Ltd reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Pharma Reaserch Prod Co Ltd Free Cash Flow Generation Index (2015–2025)
Historical FCF Generation Index trend for Pharma Reaserch Prod Co Ltd across 11 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Pharma Reaserch Prod Co Ltd.
Annual Free Cash Flow Generation for Pharma Reaserch Prod Co Ltd (2015–2025)
Year-by-year Free Cash Flow Generation Index for Pharma Reaserch Prod Co Ltd. Check Pharma Reaserch Prod Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.80x | ₩147.38 Billion | ₩183.16 Billion | ₩35.78 Billion | ▲ +13.2% |
| 2024 | 0.71x | ₩99.40 Billion | ₩139.88 Billion | ₩38.73 Billion | ▼ -10.8% |
| 2023 | 0.80x | ₩51.75 Billion | ₩64.95 Billion | ₩13.20 Billion | ▲ +13.7% |
| 2022 | 0.70x | ₩41.65 Billion | ₩59.40 Billion | ₩17.76 Billion | ▲ +10.3% |
| 2021 | 0.64x | ₩41.51 Billion | ₩65.30 Billion | ₩20.64 Billion | ▲ +788.4% |
| 2020 | -0.09x | ₩-2.99 Billion | ₩32.39 Billion | ₩34.78 Billion | ▼ -106.2% |
| 2019 | 1.50x | ₩28.86 Billion | ₩19.27 Billion | ₩9.59 Billion | ▼ -76.9% |
| 2018 | 6.50x | ₩33.80 Billion | ₩5.20 Billion | ₩28.60 Billion | ▲ +243.3% |
| 2017 | 1.89x | ₩16.19 Billion | ₩8.56 Billion | ₩7.63 Billion | ▲ +52.6% |
| 2016 | 1.24x | ₩10.12 Billion | ₩8.16 Billion | ₩1.96 Billion | ▲ +20.5% |
| 2015 | 1.03x | ₩16.49 Billion | ₩16.02 Billion | ₩462.99 Million | — |